We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$999B
AUM Growth
+$24.7B
Cap. Flow
-$14B
Cap. Flow %
-1.41%
Top 10 Hldgs %
24.27%
Holding
2,908
New
248
Increased
1,171
Reduced
1,334
Closed
66

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$3.3B
2
LLY icon
Eli Lilly
LLY
+$2.75B
3
AZN icon
AstraZeneca
AZN
+$1.98B
4
CPNG icon
Coupang
CPNG
+$1.54B
5
FTNT icon
Fortinet
FTNT
+$1.48B

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$2.34B
2
MS icon
Morgan Stanley
MS
+$2.26B
3
ABNB icon
Airbnb
ABNB
+$2.04B
4
QCOM icon
Qualcomm
QCOM
+$1.95B
5
NVDA icon
NVIDIA
NVDA
+$1.81B

Sector Composition

Rank Sector Weight
1 Technology 23.35%
2 Healthcare 16.19%
3 Consumer Discretionary 15.55%
4 Financials 12.84%
5 Communication Services 12.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRM icon
2676
Vroom Inc
VRM
$51.2M
$203K ﹤0.01%
65
-188,386
-100% -$610M
XBIT icon
2677
XBiotech
XBIT
$72.6M
$203K ﹤0.01%
+11,814
New +$221K
NBEV
2678
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$203K ﹤0.01%
70,896
+59,379
+516% +$182K
ETNB
2679
DELISTED
89bio
ETNB
$202K ﹤0.01%
8,513
-6,428
-43% -$148K
NFE icon
2680
New Fortress Energy
NFE
$93.2M
$202K ﹤0.01%
4,400
CATC
2681
DELISTED
CAMBRIDGE BANCORP
CATC
$201K ﹤0.01%
+2,378
New +$186K
NGS icon
2682
Natural Gas Services Group
NGS
$478M
$200K ﹤0.01%
21,188
-6,600
-24% -$62.8K
CALA
2683
DELISTED
Calithera Biosciences, Inc
CALA
$196K ﹤0.01%
4,047
+1,250
+45% +$72.8K
FUSB icon
2684
First US Bancshares
FUSB
$90.7M
$195K ﹤0.01%
20,950
ENZ
2685
DELISTED
Enzo Biochem, Inc.
ENZ
$194K ﹤0.01%
56,363
-37,918
-40% -$118K
PRTY
2686
DELISTED
Party City Holdco Inc.
PRTY
$194K ﹤0.01%
+33,400
New +$243K
AMPE
2687
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$191K ﹤0.01%
377
-150
-28% -$77.4K
GBDC icon
2688
Golub Capital BDC
GBDC
$3.47B
$190K ﹤0.01%
13,000
GLRE icon
2689
Greenlight Captial
GLRE
$512M
$190K ﹤0.01%
21,817
-47
-0.2% -$385
FARM
2690
DELISTED
Farmer Brothers
FARM
$189K ﹤0.01%
18,070
-2,107
-10% -$15.2K
CHMI
2691
Cherry Hill Mortgage Investment Corp
CHMI
$108M
$188K ﹤0.01%
20,136
+8,595
+74% +$82K
INOD icon
2692
Innodata
INOD
$2.02B
$187K ﹤0.01%
+29,700
New +$190K
AWH
2693
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$187K ﹤0.01%
1,844
-776
-30% -$85.3K
QUMU
2694
DELISTED
Qumu Corp.
QUMU
$187K ﹤0.01%
27,650
-3,200
-10% -$26.6K
KLDO
2695
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$186K ﹤0.01%
22,927
+11,710
+104% +$128K
WATT icon
2696
Energous
WATT
$91.6M
$184K ﹤0.01%
+76
New +$176K
NPKI
2697
NPK International
NPKI
$1.19B
$184K ﹤0.01%
+58,702
New +$181K
TCON
2698
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$184K ﹤0.01%
1,120
+425
+61% +$81.8K
AFI
2699
DELISTED
Armstrong Flooring, Inc.
AFI
$184K ﹤0.01%
37,600
AQMS icon
2700
Aqua Metals
AQMS
$9.85M
$183K ﹤0.01%
+226
New +$219K

Similar funds

T. Rowe Price Associates's Q1 2021 Portfolio in Review

As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
  • T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
  • T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
  • T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
  • T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
  • T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
  • T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.

Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.